AMGEN INC Depreciation & Amortization 2007-2026 | AMGN
Beta
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is AMGEN INC's current depreciation & amortization?
AMGEN INC (AMGN) annual depreciation & amortization for 2025 was $5.17B, a 7.60% decline from 2024. AMGEN INC depreciation & amortization for the quarter ending March 31, 2026 was $1.12B.
What was AMGEN INC's depreciation & amortization in 2024?
AMGEN INC annual depreciation & amortization for 2024 was $5.59B, a 37.36% increase from 2023.
What was AMGEN INC's depreciation & amortization in 2023?
AMGEN INC annual depreciation & amortization for 2023 was $4.07B, a 19.14% increase from 2022.
What is AMGEN INC's 5-year depreciation & amortization CAGR?
AMGEN INC depreciation & amortization grew at a compound annual growth rate (CAGR) of 7.49% from FY2020 to FY2025, going from $3.60B to $5.17B over 5 years.
Depreciation & Amortization History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+7.5%
FY2020
$3.60B
→
FY2025
$5.17B
07080910111213141516171819202122232425
5 years selected
Depreciation & Amortization History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $5.17B | -7.6% | 10-K |
| FY2024 | $5.59B | +37.4% | 10-K |
| FY2023 | $4.07B | +19.1% | 10-K |
| FY2022 | $3.42B | +0.6% | 10-K |
| FY2021 | $3.40B | -5.6% | 10-K |
| FY2020 | $3.60B | +63.2% | 10-K |
| FY2019 | $2.21B | +13.4% | 10-K |
| FY2018 | $1.95B | -0.5% | 10-K |
| FY2017 | $1.96B | -7.1% | 10-K |
| FY2016 | $2.10B | -0.1% | 10-K |
| FY2015 | $2.11B | +0.8% | 10-K |
| FY2014 | $2.09B | +62.7% | 10-K |
| FY2013 | $1.29B | +18.2% | 10-K |
| FY2012 | $1.09B | +2.6% | 10-K |
| FY2011 | $1.06B | +4.2% | 10-K |
| FY2010 | $1.02B | -3.1% | 10-K |
| FY2009 | $1.05B | -2.2% | 10-K |
| FY2008 | $1.07B | -10.7% | 10-K |
| FY2007 | $1.20B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →